Progyny (PGNY) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Progyny, Inc. Announces Third Quarter 2022 Results
November 3, 2022 4:01 PM EDTReceives Record Number of New Client Commitments in Selling SeasonReports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year PeriodRaises Full Year 2022 Guidance, Reflecting Fourth Quarter Revenue Growth of 59% to 67%
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (Progyny or the Company), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30, 2022 (the third quarter of 2022) as compared to the three-month period ended September 30, 2021 (the third quarter of 2021 or the prior year period).
... More